Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Othman S. Akhtar MBBS

Othman S. Akhtar MBBS profile photo picture

Assistant Professor

Institution: Medical College of Wisconsin
Department: Medicine
Division: Hematology and Oncology - Medicine
Program: Hematology

Member of the Center for International Blood and Marrow Transplant Research (CIBMTR)

View Curriculum Vitae

Publications (12)

  • Simple Score of Albumin and CRP Predicts High-Grade Toxicity in Patients with Multiple Myeloma Receiving CAR-T Therapy. (Akhtar OS, Modi K, Kim J, Skelson L, Smith E, Al-Jumayli MA, Extermann M, De Avila G, Parker N, Castaneda Puglianini O, Grajales Cruz A, Baz R, Blue B, Shain K, Alsina M, Liu H, Nishihori T, Jain MD, Locke FL, Hansen DK, Freeman CL) Transplant Cell Ther 2024 Mar;30(3):283.e1-283.e10 PMID: 38123069 SCOPUS ID: 2-s2.0-85183551361 12/21/2023    
  • Safety and efficacy of anti-BCMA CAR-T cell therapy in older adults with multiple myeloma: A systematic review and meta-analysis. (Akhtar OS, Sheeba BA, Azad F, Alessi L, Hansen D, Alsina M, Baz R, Shain K, Grajales Cruz A, Castaneda Puglianini O, Liu H, Blue B, Nishihori T, Al Jumayli M, Extermann M, Locke FL, Mhaskar R, Freeman CL) J Geriatr Oncol 2024 Mar;15(2):101628 PMID: 37723045 SCOPUS ID: 2-s2.0-85171674972 09/19/2023       3 Citations
  • CAR T-cell therapy has comparable efficacy with autologous transplantation in older adults with DLBCL in partial response. (Akhtar OS, Cao B, Wang X, Torka P, Al-Jumayli M, Locke FL, Freeman CL) Blood Adv 2023 Oct 10;7(19):5937-5940 PMID: 37236167 PMCID: PMC10562759 SCOPUS ID: 2-s2.0-85174038856 05/27/2023       1 Citation
  • Geriatric assessment in older adults with non-Hodgkin lymphoma: A Young International Society of Geriatric Oncology (YSIOG) review paper. (Akhtar OS, Huang LW, Tsang M, Torka P, Loh KP, Morrison VA, Cordoba R) J Geriatr Oncol 2022 Jun;13(5):572-581 PMID: 35216939 PMCID: PMC9232919 SCOPUS ID: 2-s2.0-85125353864 02/27/2022       9 Citations
  • Frequency and timing of other primary cancers in patients with chronic lymphocytic leukemia (CLL): a 17-year longitudinal study. (Akhtar OS, Groman A, Singh A, Ghione P, Lund I, Hernandez-Ilizaliturri FJ, Torka P) Leuk Lymphoma 2022 May;63(5):1127-1136 PMID: 35152821 SCOPUS ID: 2-s2.0-85125226130 02/15/2022       3 Citations
  • Ofatumumab plus HyperCVAD/HD-MA induction leads to high rates of minimal residual disease negativity in patients with newly diagnosed mantle cell lymphoma: Results of a phase 2 study. (Torka P, Akhtar OS, Reddy NM, Baysal BE, Kader A, Groman A, Nichols J, Mavis C, Tario JD, Block AW, Sait SNJ, Ghione P, Sundaram S, Przespolewski ER, Mohr A, Lund I, Kostrewa J, McWhite K, DeMarco J, Johnson M, Darrall A, Thomas-Talley RN, Wallace PK, Neppalli V, Hutson A, Hernandez-Ilizaliturri FJ) Cancer 2022 Apr 15;128(8):1595-1604 PMID: 35157306 PMCID: PMC10086838 SCOPUS ID: 2-s2.0-85124534234 02/15/2022       1 Citation
  • Anti-Xa based dosing of enoxaparin in hematopoietic stem cell transplant and adoptive cell therapy patients: A single center experience. (Jizzini M, Akhtar OS, Atwood K, Ji W, Pleskow J, Bat T, Balderman S) Thromb Res 2022 Mar;211:6-9 PMID: 35051832 SCOPUS ID: 2-s2.0-85123020405 01/21/2022    
  • Assessment of the Efficacy of Therapies Following Venetoclax Discontinuation in CLL Reveals BTK Inhibition as an Effective Strategy. (Mato AR, Roeker LE, Jacobs R, Hill BT, Lamanna N, Brander D, Shadman M, Ujjani CS, Yazdy MS, Perini GF, Pinilla-Ibarz JA, Barrientos J, Skarbnik AP, Torka P, Pu JJ, Pagel JM, Gohil S, Fakhri B, Choi M, Coombs CC, Rhodes J, Barr PM, Portell CA, Parry H, Garcia CA, Whitaker KJ, Winter AM, Sitlinger A, Khajavian S, Grajales-Cruz AF, Isaac KM, Shah P, Akhtar OS, Pocock R, Lam K, Voorhees TJ, Schuster SJ, Rodgers TD, Fox CP, Martinez-Calle N, Munir T, Bhavsar EB, Bailey N, Lee JC, Weissbrot HB, Nabhan C, Goodfriend JM, King AC, Zelenetz AD, Dorsey C, Bigelow K, Cheson BD, Allan JN, Eyre TA) Clin Cancer Res 2020 Jul 15;26(14):3589-3596 PMID: 32198151 PMCID: PMC8588795 SCOPUS ID: 2-s2.0-85084371263 03/22/2020       84 Citations
  • Dose reductions in ibrutinib therapy are not associated with inferior outcomes in patients with chronic lymphocytic leukemia (CLL). (Akhtar OS, Attwood K, Lund I, Hare R, Hernandez-Ilizaliturri FJ, Torka P) Leuk Lymphoma 2019 Jul;60(7):1650-1655 PMID: 30601100 SCOPUS ID: 2-s2.0-85059557994 01/03/2019       28 Citations
  • Contemporary Trends and Comparative Outcomes With Adjunctive Inferior Vena Cava Filter Placement in Patients Undergoing Catheter-Directed Thrombolysis for Deep Vein Thrombosis in the United States: Insights From the National Inpatient Sample. (Akhtar OS, Lakhter V, Zack CJ, Hussain H, Aggarwal V, Oliveros E, Brailovsky Y, Zhao H, Dhanisetty R, Charalel RA, Zhao M, Bashir R) JACC Cardiovasc Interv 2018 Jul 23;11(14):1390-1397 PMID: 30025732 SCOPUS ID: 2-s2.0-85049462385 07/22/2018       18 Citations
  • An Unusual Case of Vaginal Bleeding in an 18-Year-Old Female. (Akhtar OS, Deodhar KK, Dutta A, Jabeen F, Akhtar SS) J Obstet Gynaecol India 2017 Oct;67(5):372-375 PMID: 28867890 PMCID: PMC5561749 SCOPUS ID: 2-s2.0-85006371425 09/05/2017    
  • Acute lymphoblastic leukemia presenting as a breast lump: A report of two cases. (Besina S, Rasool Z, Samoon N, Akhtar OS) J Cytol 2013 Jul;30(3):201-3 PMID: 24130415 PMCID: PMC3793360 SCOPUS ID: 2-s2.0-84884544252 10/17/2013       8 Citations
    • Last update: 04/11/2024